Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating because that oh-so-familiar routine of meetings, deadlines, and what-not has returned. You knew this was coming, though, because the world keeps spinning no matter how we try to slow it down. So what else can be done but to try to cope with a refreshing cup or three of stimulation? We are indulging our habit with a spot of southern pecan and, as always, invite you to join us. Meanwhile, here are some tidbits to get you going. Have a smashing day and do keep in touch. …

Sen. Ron Wyden (D-Ore.) is challenging the Trump administration to explain how negotiating trade agreements will help lower drug prices for Americans. “If recent experience from tax legislation … is any indication, drug companies will not use their windfall to lower the price of their products,” he wrote in this May 18 letter. “The notion that pharmaceutical companies will voluntarily pass along increased revenue abroad to domestic consumers is both baffling and belied by all recent evidence.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Re Allergan – it appears that Mr Tepper, the head of Appaloosa, may have gone to Florida but has not forgotten ‘his Jersey roots.’ The new HQ of Allergan is less than 4 miles from his firms HQ in Short Hills. Nice to see he can skip the taxes but choose to add aggravation ‘back up North.’

Comments are closed.